Almost all psych drug use is unnecessary, claims doctor researching medical holocaust of over 5 million psych med victims

Monday, July 20, 2015
By Paul Martin

by: Jonathan Benson
NaturalNews.com
Monday, July 20, 2015

More than half a million people age 65 years or older die every year in the West from psychiatric drug use, and the worst part is that these death pills aren’t even effective at treating either mental illness or depression. Researchers from Denmark’s Nordic Cochrane Centre found that the benefits of psych drugs are minimal at best, and that most people who currently use them would be better off just ditching them entirely.

Published in The BMJ (British Medical Journal), an eye-opening paper by Professor Peter Gotzsche reveals that most antidepressants and dementia drugs are generally useless when it comes to providing tangible relief. The drugs are also vastly overprescribed, he says, and they come with such a high risk of adverse effects that it isn’t even worth it for the average person to try them.

Meanwhile, hundreds of thousands of people are dying every year from the normal and prescribed use of psych meds like selective serotonin reuptake inhibitors (SSRIs), which are linked to causing extreme depression and provoking users towards suicide or even homicide. Add to this the fact that most psych meds have never been shown effective, matching or not even reaching placebo in terms of their efficacy, and there’s no legitimate reason for their continued use.

“Their benefits would need to be colossal to justify this, but they are minimal,” Gotzsche warns about the more than half a million people age 65 and older in the West who die annually from psych med use. “Given their lack of benefit, I estimate we could stop almost all psychotropic drugs without causing harm.”

Drug companies fund fake trials to make psych meds appear safe and effective

The Rest…HERE

Leave a Reply

Join the revolution in 2018. Revolution Radio is 100% volunteer ran. Any contributions are greatly appreciated. God bless!

Follow us on Twitter